Denali Therapeutics Appoints Katie Peng as Chief Commercial Officer

Go back to Denali Therapeutics Appoints Katie Peng as Chief Commercial Officer
(NASDAQ: DNLI) Delayed: 22.85 -0.41 (1.76%)
Previous Close $23.26    52 Week High
Open $23.33    52 Week Low
Day High $23.86    P/E N/A 
Day Low $22.53    EPS
Volume 1,768,580